How pharma–hospital partnerships can overcome operational, financial, and organizational barriers to build high-performing clinical trial programs that expand access, accelerate accrual, and ...

Explore methods to evaluate recruitment performance across multiple platforms, including engagement tracking, conversion ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

Understand the regulatory and policy considerations for running clinical trial recruitment campaigns on nontraditional or ...

Learn how demographic and behavioral insights inform platform-specific messaging, creative formats, and call-to-action ...

New 48-week data from the Phase IIIb APEX trial (NCT04882098) show Tremfya (guselkumab; Johnson & Johnson) produces sustained inhibition of radiographic progression and improved clinical symptoms in ...

ACT: At this year’s SCRS Summit, several site representatives raised concerns about overly complex protocols and patient ...

Epkinly plus rituximab and lenalidomide is the first bispecific antibody combination FDA-approved for relapsed or refractory follicular lymphoma, backed by Phase III data showing substantially ...

In today’s ACT Brief, we look at how Trialbee evaluates nontraditional digital platforms for patient recruitment, review new ...

Explore which factors—audience relevance, content fit, and engagement quality—determine the best use of platforms like TikTok ...

Data-driven planning aids in the design of feasible clinical trials from the outset, by simulating enrollment before the ...

How sponsors can leverage technology to enhance, not hinder, site efficiency and usability Strategies to incorporate site ...